| Literature DB >> 28566371 |
Karen Cerosaletti1, Fariba Barahmand-Pour-Whitman2, Junbao Yang3, Hannah A DeBerg2, Matthew J Dufort2, Sara A Murray2, Elisabeth Israelsson2, Cate Speake4, Vivian H Gersuk2, James A Eddy2, Helena Reijonen4, Carla J Greenbaum4, William W Kwok3, Erik Wambre3, Martin Prlic5, Raphael Gottardo5, Gerald T Nepom6, Peter S Linsley7.
Abstract
The significance of islet Ag-reactive T cells found in peripheral blood of type 1 diabetes (T1D) subjects is unclear, partly because similar cells are also found in healthy control (HC) subjects. We hypothesized that key disease-associated cells would show evidence of prior Ag exposure, inferred from expanded TCR clonotypes, and essential phenotypic properties in their transcriptomes. To test this, we developed single-cell RNA sequencing procedures for identifying TCR clonotypes and transcript phenotypes in individual T cells. We applied these procedures to analysis of islet Ag-reactive CD4+ memory T cells from the blood of T1D and HC individuals after activation with pooled immunodominant islet peptides. We found extensive TCR clonotype sharing in Ag-activated cells, especially from individual T1D subjects, consistent with in vivo T cell expansion during disease progression. The expanded clonotype from one T1D subject was detected at repeat visits spanning >15 mo, demonstrating clonotype stability. Notably, we found no clonotype sharing between subjects, indicating a predominance of "private" TCR specificities. Expanded clones from two T1D subjects recognized distinct IGRP peptides, implicating this molecule as a trigger for CD4+ T cell expansion. Although overall transcript profiles of cells from HC and T1D subjects were similar, profiles from the most expanded clones were distinctive. Our findings demonstrate that islet Ag-reactive CD4+ memory T cells with unique Ag specificities and phenotypes are expanded during disease progression and can be detected by single-cell analysis of peripheral blood.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28566371 PMCID: PMC5499675 DOI: 10.4049/jimmunol.1700172
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422